|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Lung Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Lung Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Lung Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| Respiratory Tract Diseases | |||||
| Respiratory Tract Neoplasms | |||||
| Thoracic Neoplasms | |||||
| 4 | Interventions listed in this trial | ||||
| KOS-862 | |||||
| 5 | Sponsors listed in this trial | ||||
| Bristol-Myers Squibb | |||||